| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $5.50B | +6.0% |
| Cost of Revenue | $2.20B | +5.6% |
| Gross Profit | $3.30B | +6.2% |
| R&D Expense | $266.0M | +5.1% |
| SG&A Expense | $1.76B | +6.8% |
| Operating Income | $1.28B | +5.7% |
| Pre-tax Income | $1.17B | +8.0% |
| Income Tax | $233.0M | -7.9% |
| Net Income | $940.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.03B | +84.5% |
| Accounts Receivable | $897.0M | +10.5% |
| Inventory | $307.0M | +6.6% |
| Current Assets | $3.43B | +43.8% |
| Total Assets | $7.69B | +20.1% |
| Current Liabilities | $2.06B | +65.1% |
| Long-term Debt | $2.67B | +2.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.08B | +23.1% |
| Capital Expenditures | $63.0M | +14.5% |
| Investing Cash Flow | -$98.0M | +77.4% |
| Financing Cash Flow | -$102.0M | -56.9% |
| Free Cash Flow | $1.01B | +23.7% |
| +12.8% |
| EPS (Basic) | $3.79 | +12.5% |
| EPS (Diluted) | $3.76 | +12.6% |
| Stockholders' Equity |
| $3.10B |
| +52.4% |